Case Study: Chikungunya and Lupus, an Ill-Fated Diagnosis
Diagnosed with systemic lupus erythematosus and chikungunya, a woman embarks on a cross-continent trip for treatment and diagnosis at a city hospital.
ACR 2016 Opening Talk: Healthcare via Smartphone
How the “The Internet of Healthy Things” is improving healthcare delivery.
Rheumatologist vs Dr. Google: Battling Misinformation
Medical misinformation is abundant online. The president and co-founder of the Global Healthy Living Foundation and CreakyJoints offers rheumatologists some tips with Dr. Google.
A Weeping Wound with Ragged Edges and a Putrid Odor
Case Study: A female patient presents with a case of pyoderma gangrenosum that fails multiple standard treatments.
Where Innate Immunity and Autoimmune Disease Intersect
In this article, we discuss the possibility of innate lymphocytes as therapeutic targets in rheumatic disease as described in Nature Reviews Rheumatology.
Pain as the Sixth Vital Sign
Doctors, remember that pain is subjective and may not fall easily into a grading system, writes Dr. Irina Litvin, a rheumatology fellow at SUNY Downstate in Brooklyn, N.Y.
Uveitis Patient Selection Key for Adalimumab Treatment
Adalimumab for the treatment of noninfectious uveitis has advantages over no treatment or conventional treatment with steroid therapy.
Healthcare Reform for Rheumatologists, Take-a-Way Lessons
In this interview, Herbert S. B. Baraf, MD, FACP, MACR, provides his take-a-ways from ACR/ARHP 2015 about new reimbursement policies affecting private practice rheumatologists.
Too Late for Methotrexate
Aggressive treatment early in rheumatoid arthritis is the accepted practice today. In this slideshow, Dr. Litvin reminds us of patients diagnosed in the pre-biologics era.
Eight Things You Need to Know About Talking with Your Patients
Sometimes it’s not enough to ask "How are you feeling?” In this slideshow, we list eight communication pitfalls physicians should avoid.
By clicking Accept, you agree to become a member of the UBM Medica Community.